Ridgefield, CT, United States of America

Robert Lipper

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Thetis Pharmaceuticals LLC. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Robert Lipper: Innovator in Specialized Pro-Resolving Mediators

Introduction

Robert Lipper is a notable inventor based in Ridgefield, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of specialized pro-resolving mediators. His work focuses on enhancing the therapeutic potential of these mediators through innovative formulations.

Latest Patents

Robert Lipper holds a patent for "Cyclodextrin complexes of specialized pro-resolving mediators." This invention provides complexes of a specialized pro-resolving mediator (SPM), or a salt, ester, or amide thereof, and a cyclodextrin (CD). The SPM is a hydroxylated, polyunsaturated fatty acid derived from arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, or docosapentaenoic acid, with 20 or 22 carbon atoms in length. It features 4, 5, or 6 conjugated double bonds arranged in diene, triene, or tetraene systems or combinations thereof. This patent represents a significant advancement in the field of medicinal chemistry.

Career Highlights

Robert Lipper is associated with Thetis Pharmaceuticals LLC, where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has led to the creation of valuable intellectual property that contributes to advancements in healthcare.

Collaborations

Robert has collaborated with notable professionals in his field, including Gary Mathias and Frank C Sciavolino. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Robert Lipper is a distinguished inventor whose work in specialized pro-resolving mediators has the potential to impact the pharmaceutical industry significantly. His contributions through patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…